Monday, May 18, 2026

Augmented AI and AMA Thinking: Wishful Thinking?

›
There's a new paper going the rounds of commentary at Linked In: Open access; find it here . See comment at LinkedIn by Jan Beger here ....
Friday, May 15, 2026

Dr Bien-Willner Is Departing MolDx - An Update

›
  Gabriel Bien-Willner to Transition Out of MolDX Medical Director Role May 15, 2025  (Columbia, SC) LinkedIn by GBW: here . Gabriel A. Bien...
Thursday, May 14, 2026

Digital Pathology Dollars. Re-live the Film-Digital Switchover at the RVU Ranch.

›
What’s Past Is Prologue:  Medicare, Radiology, and the Strange Migration from Film to Digital ## The CMS-RVU migration from film to digital ...

Updated: Amal Thommil's MRD Roadmap

›
 Amal Thommil of DeciBio updates his map of MRD coverage in oncology. Find it here: https://www.linkedin.com/posts/amalthommil_reimbursement...

AI Guest Column: Chat GPT on TROP2 CDx from Roche Diagnostics Day

›
  A previous blog summarized the 3-hour, annual Roche Diagnostics Day. I asked Chat GPT to go back to the transcript and discuss the news a...

AI Guest Column: ChatGPT & Opus: Roche Diagnostics Day

›
On May 12, 2026, Roche held its annual Diagnostics Day with a 3-hour webinar and a 150-slide deck. Find them here:   https://www.roche.com/i...

To Fix Software and AI Reimbursement - Do We Need to Understand the RUC?

›
To Fix Software and AI Reimbursement - Do We Need to Understand the RUC? Maybe. For at least five years, CMS has had difficulty pricing soft...

Understanding FDA Regulatory Documents for Digital Pathology: PAIGE and ARTERA-AI

›
We often hear there are 1000 FDA software/AI devices or SaMD for radiology, and only a few for pathology. Let's look at pathology, and s...
Monday, May 11, 2026

WISeR Prior Authorization - It's Worse Than We Knew. Case study: DBS in PD.

›
Announced last summer, CMS has now instituted the WISeR program to force prior authorization into Medicare Part B using outside venders and ...

AI Guest Column: Will Genomics Move In-House or to Send-Out?

›
Header: For years, one of the Grand Questions in genomics has been "in house versus send out."  I asked Claude Opus 4.7 to write ...

AI Guest Column: What Next for ArteraAI?

›
Header: Digital pathology at warp speed - Tempus acquires Paige, Roche aquires PathAI, ArteraAI gets a true FDA application (Breast cancer p...